{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:18Z","timestamp":1787166678067,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/rhu.0b013e3181e969b9","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T21:33:04Z","timestamp":1280179984000},"page":"244-245","source":"Crossref","is-referenced-by-count":56,"title":["Clinical Efficacy of Etanercept for Treatment of PAPA Syndrome"],"prefix":"10.1097","volume":"16","author":[{"given":"Nathan D.","family":"Tofteland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"Shaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210207","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","article-title":"Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome [abstract].","volume":"22","author":"Stichweh","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"R2-12-20210207","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder.","volume":"11","author":"Wise","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R3-12-20210207","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2008.11.017","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene.","volume":"61","author":"Hong","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R4-12-20210207","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.2135380100","article-title":"Pyrin binds the PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway.","volume":"100","author":"Shoham","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R5-12-20210207","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00130832-200212000-00006","article-title":"The autoinflammatory syndromes.","volume":"2","author":"McDermott","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R6-12-20210207","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1086","article-title":"NODs: intracellular proteins involved in inflammation and apoptosis.","volume":"3","author":"Inohara","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R7-12-20210207","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/rheumatology\/kei178","article-title":"Peculiarities of PAPA syndrome.","volume":"45","author":"Tallon","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R8-12-20210207","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.mcna.2009.08.008","article-title":"Acne and systemic disease.","volume":"93","author":"Lolis","year":"2009","journal-title":"Med Clin North Am"},{"key":"R9-12-20210207","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2004.08.001","article-title":"Abnormal production of the tumour necrosis factor alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome.","volume":"145","author":"Cortis","year":"2004","journal-title":"J Pediatr"},{"key":"R10-12-20210207","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00124743-200210000-00009","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA Syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-[alpha] levels.","volume":"8","author":"Edrees","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"R11-12-20210207","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/01.rhu.0000111315.94725.9c","article-title":"Successful use of etanercept in a patient with pyoderma gangrenosum complicating rheumatoid arthritis.","volume":"10","author":"Disla","year":"2004","journal-title":"J Clin Rheumatol"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124743-201008000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:32:06Z","timestamp":1786041126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124743-201008000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3181e969b9","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}